Holen Sie sich die Stockscreener-App
529.70
0.73%
3.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$525.88
Offen:
$525.73
24-Stunden-Volumen:
2.29M
Relative Volume:
1.91
Marktkapitalisierung:
$118.45B
Einnahmen:
$75.60B
Nettoeinkommen (Verlust:
$7.78B
KGV:
18.66
EPS:
28.3842
Netto-Cashflow:
$7.69B
1W Leistung:
-0.49%
1M Leistung:
+4.72%
6M Leistung:
+30.77%
1J Leistung:
+65.05%
1-Tages-Spanne:
$523.10
$532.69
1-Wochen-Bereich:
$522.05
$547.05
52-Wochen-Spanne:
$295.00
$552.90
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, FMS, UHS, ENSG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
529.70 | 117.60B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
239.39 | 20.84B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.46 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
206.10 | 12.77B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
214.17 | 12.36B | 4.11B | 239.98M | 193.10M | 4.12 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA's TriStar Division eyes Fairview for $21M freestanding ER - The Business Journals
This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year - The Motley Fool
How Is HCA Healthcare's Stock Performance Compared to Other Healthcare Providers Stocks? - FinancialContent
Part I: Northeast Florida health care development update: HCA, Baptist and Ascension St. Vincent's - Jacksonville Daily Record
Nurse sues HCA Florida Palms West Hospital, security company 1 year after brutal patient attack - WPTV
HCA Healthcare, Inc. to Present at March Conferences - The Joplin Globe
HCA Healthcare stock doubles in the three years, hitting new all-time high - The Business Journals
HCA Healthcare Named a World’s Most Admired Company by Fortune for the 12th Consecutive Year - Business Wire
Intech Investment Management LLC Sells 100,529 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Assessing HCA Healthcare (HCA) Valuation After Strong Recent Share Price Momentum - simplywall.st
HCA Healthcare (HCA) Announces 2026 Executive Officer Performanc - GuruFocus
A Look At HCA Healthcare (HCA) Valuation As AI Plans And Medicaid Updates Draw Analyst Upgrades - Yahoo Finance
HCA Healthcare announces 2026 executive performance plan and board retirement - Investing.com
HCA Healthcare Adopts 2026 Executive Performance Incentive Program - TipRanks
Robert J. Dennis to Retire from HCA Healthcare Board; Executive Officer PEP Adopted - TradingView
HCA Healthcare (HCA) Receives Price Target Boost from Mizuho Ana - GuruFocus
Mizuho Raises HCA Healthcare (NYSE:HCA) Price Target to $585.00 - MarketBeat
Mizuho Securities Adjusts HCA Healthcare PT to $585 From $540, Maintains Outperform Rating - marketscreener.com
HCA Healthcare, Inc. $HCA Stock Holdings Lessened by TD Asset Management Inc - MarketBeat
Magellan Asset Management Ltd Reduces Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
What HCA Healthcare (HCA)'s AI Push and Facility Expansion Means For Shareholders - Yahoo Finance
Why (HCA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
HCA Florida Healthcare Urges Residents of the 352 to Learn CPR for American Heart Month - 352today
HCA Healthcare Colleton recognizes Director - Walterboro Live
Kovitz Investment Group Partners LLC Cuts Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Chase Investment Counsel Corp Trims Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
UBS raises HCA Healthcare stock price target to $635 on AI potential By Investing.com - Investing.com Canada
UBS Raises Price Target for HCA to $635, Maintains Buy Rating | - GuruFocus
HCA Healthcare, Inc. (HCA) Stock Report: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
HCA Healthcare Could See AI-Driven Multiple Expansion, UBS Says - marketscreener.com
UBS Adjusts Price Target on HCA Healthcare to $635 From $598, Maintains Buy Rating - marketscreener.com
UBS raises HCA Healthcare stock price target to $635 on AI potential - Investing.com India
Equitable Trust Co. Sells 9,154 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Citigroup Inc. Grows Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
Premier Fund Managers Ltd Sells 9,957 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Raiffeisen Bank International AG Increases Position in HCA Healthcare, Inc. $HCA - MarketBeat
GSA Capital Partners LLP Invests $936,000 in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. $HCA Shares Sold by ANTIPODES PARTNERS Ltd - MarketBeat
HCA: JP Morgan Raises Price Target to $535 While Maintaining Neu - GuruFocus
Universal Health Q4 Earnings: Will Acute Care Offset Rising Costs? - TradingView
June 2027 Options Now Available For HCA Healthcare - Nasdaq
HCA Healthcare (NYSE:HCA) Given New $535.00 Price Target at JPMorgan Chase & Co. - MarketBeat
HCA Healthcare, Inc. $HCA Shares Sold by Value Star Asset Management Hong Kong Ltd - MarketBeat
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock - Yahoo Finance
Persistent Asset Partners Ltd Takes $1 Million Position in HCA Healthcare, Inc. $HCA - MarketBeat
JPMorgan Adjusts Price Target on HCA Healthcare to $535 From $420 - marketscreener.com
RBC Capital Remains a Buy on HCA Healthcare (HCA) - The Globe and Mail
HCA Healthcare enhances cancer support with nurse navigators - Traders Union
Community Health Q4 Earnings Beat Estimates on Lower Expenses - TradingView
NEOS Investment Management LLC Grows Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare EVP McAlevey sells $903k in stock - Investing.com
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):